Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Enanta's (ENTA) RSV Drug Fails to Meet Study Goal, Stock Drops
07:02pm, Thursday, 19'th May 2022 Zacks Investment Research
While a mid-stage study evaluating Enanta's (ENTA) RSV candidate misses out on its primary endpoint, a statistically huge number of subjects achieved undetectable RSV RNA at the end of treatment.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
10:20am, Thursday, 19'th May 2022 Zacks Investment Research
Sector ETF report for FHLC
Why Pfizer Looks Better Than Moderna as a Long-Term Buy
03:53pm, Wednesday, 18'th May 2022 The Motley Fool
In a post-COVID world, there are fewer question marks about Pfizer than there are about Moderna.
Moderna (MRNA) Stock Rises 4%: What's Behind the Upside?
02:10pm, Wednesday, 18'th May 2022 Zacks Investment Research
Moderna (MRNA) stock rises more than 4% on May 17. The COVID-19 vaccine-maker attracts investors on the back of a promising update from one of its competitors.
Pfizer (PFE) Gets EUA for Use of Comirnaty Booster in Children
02:07pm, Wednesday, 18'th May 2022 Zacks Investment Research
Pfizer (PFE) and partner BioNTech gets authorization for emergency use of booster dose of its COVID-19 vaccine, Comirnaty, in children aged between 5 years and 11 years.
Is Ocugen Finally on the Way to Vaccine Revenue?
10:30am, Wednesday, 18'th May 2022 The Motley Fool
It's entering a new market -- one that has authorized its vaccine.
The Correction In Biopharmaceutical Stocks Is Likely Over
04:51am, Wednesday, 18'th May 2022 Seeking Alpha
Biopharmaceutical stocks have undergone a dramatic correction over the past six months, with the XBI declining by 45%. I highlight stocks that are attractively priced.
Dow climbs third straight day as stocks end sharply higher after retail sales, Fed Chair Powell's remarks
08:39pm, Tuesday, 17'th May 2022 MarketWatch
U.S. stocks end sharply higher Tuesday, after retail sales data for April suggest the economy remained healthy and as investors weigh remarks by Federal Reserve Chairman Jerome Powell.
EXCLUSIVE: Be The House Not The Gambler — How To Use Options To Improve Performance
08:33pm, Tuesday, 17'th May 2022 Benzinga
While investment results in the markets are not guaranteed, there are relatively simple options strategies that can greatly reduce risk and generate far more predictable returns in the long run.
That
Why BioNTech Stock Jumped Today
07:52pm, Tuesday, 17'th May 2022 The Motley Fool
5- to 11-year-olds are now eligible to get booster shots of the Comirnaty COVID-19 vaccine.
Valneva (VALN) Down as EU Considers Ending COVID-Vaccine Deal
06:10pm, Tuesday, 17'th May 2022 Zacks Investment Research
Per the agreement with the European Commission, Valneva (VALN) has 30 days from May 13, 2022 to win a marketing authorization in the EU for its COVID vaccine or offer an acceptable remediation plan.
Pfizer’s Covid-19 booster shot cleared for children ages 5 to 11
04:13pm, Tuesday, 17'th May 2022 MarketWatch
U.S. health regulators cleared for use a booster shot of the Covid-19 vaccine from Pfizer Inc. and BioNTech SE for children 5 to 11 years, expanding booster access to about 28 million youngsters.
U.S. government is offering free COVID tests again, as cases rise 57% from two weeks ago; FDA authorizes booster for children aged 5 to 11
03:58pm, Tuesday, 17'th May 2022 MarketWatch
The federal government is again offering Americans free COVID-19 test kits through the mail, allowing for up to eight more tests to be ordered through the USPS.
The Zacks Analyst Blog Highlights NVIDIA, The Home Depot, Pfizer, The Walt Disney, and Salesforce
03:27pm, Tuesday, 17'th May 2022 Zacks Investment Research
NVIDIA, The Home Depot, Pfizer, The Walt Disney, and Salesforce are part of Zacks top Analyst Blog
Pfizer's Setbacks With Paxlovid Are Mounting -- Should Investors Be Concerned?
12:45pm, Tuesday, 17'th May 2022 The Motley Fool
It can still make a lot of money if things don't go perfectly.
